Abstract
Objectives
To evaluate the added value of diffusion-weighted imaging (DWI) on MRI in differentiating serous from mucin-producing pancreatic cystic neoplasms (PCNs).
Methods
One hundred seventeen patients with PCN measuring ≥ 10 mm were included. Three readers independently evaluated MRI with and without the use of apparent diffusion coefficient (ADC). Logistic regression was used to analyze whether confidence scores were different with the use of different image sets. Diagnostic performance with and without ADC was compared.
Results
DWI/ADC improved confidence in 44.8%, 73.6%, and 78.2% of patients by the three readers in distinguishing serous from mucin-producing PCNs. The use of ADC increased the probability of a higher confidence in the differentiation as compared to morphological imaging for all three readers (p < 0.001). Odds ratio for increase in the diagnostic confidence with the use of ADC for the three readers with decreasing years of experience were 5.8, 6.8, and 12.7. The diagnostic accuracy of morphological MRI with ADC was higher than that without ADC for two of three readers with lesser experience (87.2% vs. 80.8%; 91.5% vs. 80.8%).
Conclusion
DWI may have added value as a complementary tool to conventional morphological MRI in differentiating between serous and mucin-producing PCNs with possibly greater value for readers with less experience in reading abdominal MRI.
Key Points
• Optimal management of PCNs requires differentiation of serous from mucin-producing PCNs.
• ADC measurements allow increased confidence in differentiating serous from mucin-producing PCNs.
• ADC measurements increase the accuracy in diagnosing serous versus mucin-producing PCNs.
Similar content being viewed by others
Abbreviations
- ADC:
-
Apparent diffusion coefficient
- BD-IPMN:
-
Branch duct intraductal papillary mucinous neoplasm
- CE-MRI:
-
Contrast-enhanced magnetic resonance imaging
- CT:
-
Computed tomography
- DWI:
-
Diffusion-weighted imaging
- FNA:
-
Fine needle aspiration
- FS:
-
Fat saturation
- GRE:
-
Gradient echo
- IPMN:
-
Intraductal papillary mucinous neoplasm
- MCN:
-
Mucinous cystic neoplasm
- MD-IPMN:
-
Main duct intraductal papillary mucinous neoplasm
- MRCP:
-
Magnetic resonance cholangiopancreatography
- MRI:
-
Magnetic resonance imaging
- PCN:
-
Pancreatic cystic neoplasm
- SCA:
-
Serous cystadenoma
- SD:
-
Standard deviation
References
Zhang XP, Yu ZX, Zhao YP, Dai MH (2016) Current perspectives on pancreatic serous cystic neoplasms: diagnosis, management and beyond. World J Gastrointest Surg 8:202–211
Sahani DV, Kambadakone A, Macari M, Takahashi N, Chari S, Fernández-del Castillo C (2013) Diagnosis and management of cystic pancreatic lesions. AJR Am J Roentgenol 200:343–354
Lennon AM, Manos LL, Hruban RH et al (2014) Role of a multidisciplinary clinic in the management of patients with pancreatic cysts: a single-center cohort study. Ann Surg Oncol 21:3668–3674
Tanaka M, Fernández-del Castillo C, Adsay V et al (2012) International consensus guidelines 2012 for the management of IPMN and MCN of the pancreas. Pancreatology 12:183–197
Song SJ, Lee JM, Kim YJ et al (2007) Differentiation of intraductal papillary mucinous neoplasms from other pancreatic cystic masses: comparison of multirow-detector CT and MR imaging using ROC analysis. J Magn Reson Imaging 26:86–93
Lauenstein TC, Sharma P, Hughes T, Heberlein K, Tudorascu D, Martin DR (2008) Evaluation of optimized inversion-recovery fat-suppression techniques for T2-weighted abdominal MR imaging. J Magn Reson Imaging 27:1448–1454
Visser BC, Yeh BM, Qayyum A, Way LW, McCulloch CE, Coakley FV (2007) Characterization of cystic pancreatic masses: relative accuracy of CT and MRI. AJR Am J Roentgenol 189:648–656
Do RK, Katz SS, Gollub MJ et al (2014) Interobserver agreement for detection of malignant features of intraductal papillary mucinous neoplasms of the pancreas on MDCT. AJR Am J Roentgenol 203:973–979
Choi JY, Kim MJ, Lee JY et al (2009) Typical and atypical manifestations of serous cystadenoma of the pancreas: imaging findings with pathologic correlation. AJR Am J Roentgenol 193:136–142
Sun HY, Kim SH, Kim MA, Lee JY, Han JK, Choi BI (2010) CT imaging spectrum of pancreatic serous tumors: based on new pathologic classification. Eur J Radiol 75:e45–e55
de Jong K, Nio CY, Hermans JJ et al (2010) High prevalence of pancreatic cysts detected by screening magnetic resonance imaging examinations. Clin Gastroenterol Hepatol 8:806–811
Megibow AJ, Baker ME, Morgan DE et al (2017) Management of incidental pancreatic cysts: a white paper of the ACR Incidental Findings Committee. J Am Coll Radiol. https://doi.org/10.1016/j.jacr.2017.03.010
Correa-Gallego C, Ferrone CR, Thayer SP, Wargo JA, Warshaw AL, Fernández-Del Castillo C (2010) Incidental pancreatic cysts: do we really know what we are watching? Pancreatology 10:144–150
Valsangkar NP, Morales-Oyarvide V, Thayer SP et al (2012) 851 resected cystic tumors of the pancreas: a 33-year experience at the Massachusetts General Hospital. Surgery 152:S4–S12
Schraibman V, Goldman SM, Ardengh JC et al (2011) New trends in diffusion-weighted magnetic resonance imaging as a tool in differentiation of serous cystadenoma and mucinous cystic tumor: a prospective study. Pancreatology 11:43–51
Le Bihan D, Turner R, Douek P, Patronas N (1992) Diffusion MR imaging: clinical applications. AJR Am J Roentgenol 159:591–599
Pozzessere C, Castaños Gutiérrez SL, Corona-Villalobos CP et al (2016) Diffusion-weighted magnetic resonance imaging in distinguishing between mucin-producing and serous pancreatic cysts. J Comput Assist Tomogr 40:505–512
Sandrasegaran K, Akisik FM, Patel AA et al (2011) Diffusion-weighted imaging in characterization of cystic pancreatic lesions. Clin Radiol 66:808–814
Cicchetti DV (1994) Guidelines, criteria, and rules of thumb for evaluating normed and standardized assessment instruments in psychology. Psychol Assess 6:284–290
Boraschi P, Donati F, Gigoni R, Salemi S, Bartolozzi C, Falaschi F (2010) Diffusion-weighted MRI in the characterization of cystic pancreatic lesions: usefulness of ADC values. Magn Reson Imaging 28:1447–1455
Fatima Z, Ichikawa T, Motosugi U et al (2011) Magnetic resonance diffusion-weighted imaging in the characterization of pancreatic mucinous cystic lesions. Clin Radiol 66:108–111
Irie H, Honda H, Kuroiwa T et al (2002) Measurement of the apparent diffusion coefficient in intraductal mucin-producing tumor of the pancreas by diffusion-weighted echo-planar MR imaging. Abdom Imaging 27:82–87
Mottola JC, Sahni VA, Erturk SM, Swanson R, Banks PA, Mortele KJ (2012) Diffusion-weighted MRI of focal cystic pancreatic lesions at 3.0-tesla: preliminary results. Abdom Imaging 37:110–117
Yamashita Y, Namimoto T, Mitsuzaki K et al (1998) Mucin-producing tumor of the pancreas: diagnostic value of diffusion-weighted echo-planar MR imaging. Radiology 208:605–609
Khashab MA, Kim K, Lennon AM et al (2013) Should we do EUS/FNA on patients with pancreatic cysts? The incremental diagnostic yield of EUS over CT/MRI for prediction of cystic neoplasms. Pancreas 42:717–721
Ngamruengphong S, Lennon AM (2016) Analysis of pancreatic cyst fluid. Surg Pathol Clin 9:677–684
Sasaki M, Yamada K, Watanabe Y et al (2008) Variability in absolute apparent diffusion coefficient values across different platforms may be substantial: a multivendor, multi-institutional comparison study. Radiology 249:624–630
Barral M, Sebbag-Sfez D, Hoeffel C et al (2013) Characterization of focal pancreatic lesions using normalized apparent diffusion coefficient at 1.5-tesla: preliminary experience. Diagn Interv Imaging 94:619–627
Do RK, Chandarana H, Felker E et al (2010) Diagnosis of liver fibrosis and cirrhosis with diffusion-weighted imaging: value of normalized apparent diffusion coefficient using the spleen as reference organ. AJR Am J Roentgenol 195:671–676
Grech-Sollars M, Hales PW, Miyazaki K et al (2015) Multi-centre reproducibility of diffusion MRI parameters for clinical sequences in the brain. NMR Biomed 28:468–485
Ye XH, Gao JY, Yang ZH, Liu Y (2014) Apparent diffusion coefficient reproducibility of the pancreas measured at different MR scanners using diffusion-weighted imaging. J Magn Reson Imaging 40:1375–1381
Pandey A, Pandey P, Ghasabeh MA et al (2018) Accuracy of apparent diffusion coefficient in differentiating pancreatic neuroendocrine tumour from intrapancreatic accessory spleen. Eur Radiol 28:1560–1567
European Study Group on Cystic Tumours of the Pancreas (2018) European evidence-based guidelines on pancreatic cystic neoplasms. Gut 67:789–804
Funding
The authors state that this work has not received any funding.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Guarantor
The scientific guarantor of this publication is Ihab R. Kamel.
Conflict of interest
The authors declare that they have no conflict of interest.
Statistics and biometry
No complex statistical methods were necessary for this paper.
Informed consent
Written informed consent was waived by the institutional review board.
Ethical approval
Institutional review board approval was obtained.
Methodology
• retrospective
• diagnostic study
• performed at one institution
Additional information
Publisher’s note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Electronic supplementary material
ESM 1
(DOCX 667 kb)
Rights and permissions
About this article
Cite this article
Pandey, P., Pandey, A., Shao, N. et al. Added value of apparent diffusion coefficient in distinguishing between serous and mucin-producing pancreatic cystic neoplasms. Eur Radiol 29, 4660–4669 (2019). https://doi.org/10.1007/s00330-019-6010-9
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00330-019-6010-9